The present research showed the combination therapy of AF and ICG-001 significantly suppressed the expression of phosphorylation of STAT3 and the downstream mediator Bcl-xL both in vitro and in vivo (Figures 3, 4, 5C, G). This evidence concerns the gene BCL2L1 and atrial fibrillation.